0.10Open0.11Pre Close10 Volume2.65K Open Interest77.00Strike Price92.00Turnover48.85%IV2.53%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.1621Delta0.1214Gamma394.50Leverage Ratio-0.1750Theta-0.0003Rho-63.94Eff Leverage0.0102Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet